A Game-Changer in Liver Cancer Management: Atezolizumab-Bevacizumab Combination Extends Liver Cancer Patients’ Survival, Promises New Era in Treatment
With Atezolizumab-Bevacizumab combination median overall survival was 12 months In patients with good liver function,...